A PHARMACEUTICAL COMPOSITION
    1.
    发明公开
    A PHARMACEUTICAL COMPOSITION 审中-公开
    一种药物组合物

    公开(公告)号:EP2895155A1

    公开(公告)日:2015-07-22

    申请号:EP13760025.0

    申请日:2013-09-06

    发明人: SPLEISS, Johannes

    IPC分类号: A61K9/48 A61K31/202 A61K47/42

    摘要: Shelf life of soft gelatin capsules comprising a soft gelatin shell encapsulating a pharmaceutical formulation comprising cis-5,8,11,14,17-eicosapentaenoic acid (C20:5 n-3; "EPA") in free acid form in an amount from 25 wt % to 99 wt % of the formulation and cis-7,10,13,16,19-docosapentaenoic acid (C22:5 n-3; "DPA") in free acid form in an amount from 1 wt % to75 wt % of the formulation in which the gelatin component of the shell is Type B gelatin, is improved by replacing up to 75 wt % of the gelatin component with porcine Type A gelatin.

    摘要翻译: 包含软胶囊的软明胶胶囊的保质期,所述胶囊包含药物制剂,其包含游离酸形式的顺式-5,8,11,14,17-二十碳五烯酸(C20:5n-3;“EPA”),其量为 25wt%至99wt%的制剂和游离酸形式的顺式-7,10,13,16,19-二十二碳五烯酸(C22:5n-3;“DPA”),其量为1wt%至75wt% 通过用猪A型明胶替换至多75重量%的明胶组分来改进其中壳的明胶组分为B型明胶的配方的%。